Inducible nitric oxide synthase activation by interleukin-17

被引:112
作者
Miljkovic, D
Trajkovic, V
机构
[1] Univ Belgrade, Inst Microbiol & Immunol, Sch Med, YU-11000 Belgrade, Serbia
[2] Inst Biol Res, Belgrade, Serbia
关键词
IL-17; nitric oxide; iNOS; autoimmunity;
D O I
10.1016/j.cytogfr.2003.10.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-17 (IL-17) is a proinflammatory T cell cytokine presumably involved in physiological responses to infection, but also in immunopathology of autoimmune disorders such as rheumatoid arthritis. The proinflammatory action of IL-17 depends considerably on its ability to trigger the expression of inducible nitric oxide (NO) synthase (iNOS), an enzyme responsible for the generation of cytotoxic and immunoregulatory free radical NO. Here we discuss the role of IL-17 in the cytokine network controlling iNOS expression, and analyze signaling pathways employed by IL-17 for the initiation of iNOS gene transcription. We also propose biological consequences of IL-17-mediated NO release that could be relevant for the mechanisms or therapy of autoimmune and inflammatory disorders. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 107 条
[61]   Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis [J].
Matusevicius, D ;
Kivisäkk, P ;
He, B ;
Kostulas, N ;
Özenci, V ;
Fredrikson, S ;
Link, H .
MULTIPLE SCLEROSIS JOURNAL, 1999, 5 (02) :101-104
[62]   Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli [J].
Meeuwsen, S ;
Persoon-Deen, C ;
Bsibsi, M ;
Ravid, R ;
Van Noort, JM .
GLIA, 2003, 43 (03) :243-253
[63]   The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells [J].
Miljkovic, D ;
Cvetkovic, I ;
Vuckovic, O ;
Stosic-Grujicic, S ;
Stojkovic, MM ;
Trajkovic, V .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (03) :518-525
[64]   IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines [J].
Molet, S ;
Hamid, Q ;
Davoine, F ;
Nutku, E ;
Taha, R ;
Pagé, N ;
Olivenstein, R ;
Elias, J ;
Chakir, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (03) :430-438
[65]   Interleukin-17 family and IL-17 receptors [J].
Moseley, TA ;
Haudenschild, DR ;
Rose, L ;
Reddi, AH .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (02) :155-174
[66]  
Nielsen OH, 2003, SCAND J GASTROENTERO, V38, P180, DOI 10.1080/00365520310000672
[67]   Interleukin-17 promotes angiogenesis and tumor growth [J].
Numasaki, M ;
Fukushi, J ;
Ono, M ;
Narula, SK ;
Zavodny, PJ ;
Kudo, T ;
Robbins, PD ;
Tahara, H ;
Lotze, MT .
BLOOD, 2003, 101 (07) :2620-2627
[68]  
Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598
[69]   Hypoestoxide, a novel anti-inflammatory natural diterpene, inhibits the activity of IκB kinase [J].
Ojo-Amaize, EA ;
Kapahi, P ;
Kakkanaiah, VN ;
Takahashi, T ;
Shalom-Barak, T ;
Cottam, HB ;
Adesomoju, AA ;
Nchekwube, EJ ;
Oyemade, OA ;
Karin, M ;
Okogun, JI .
CELLULAR IMMUNOLOGY, 2001, 209 (02) :149-157
[70]  
Pacquelet S, 2002, J RHEUMATOL, V29, P2602